主管单位:中华人民共和国
国家卫生健康委员会
主办单位:
总编辑:杨秋
编辑部主任:吴翔宇
邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)
英文关键词:
川崎病又称皮肤黏膜淋巴结综合征,是一种原因不明的以全身血管炎为主要病变的发热出疹性疾病。病变主要累及全身中、小血管,尤其是冠状动脉损害较多,包括冠状动脉扩张、冠状动脉瘤、冠状动脉狭窄甚至血栓形成。输注丙种球蛋白(IVIG)联合阿司匹林是急性期川崎病的标准治疗方案,但约有10%~20%的川崎病患儿对单次注射IVIG(2 g/kg)联合阿司匹林并无效果,称为IVIG无反应型川崎病。该部分患儿出现冠状动脉损害甚至冠状动脉瘤的风险明显升高,国内外文献报道有多种治疗IVIG无反应型川崎病的方法,包括IVIG追加治疗、糖皮质激素、肿瘤坏死因子α抑制剂(英夫利昔单抗)、阿昔单抗、钙调节神经蛋白抑制剂(环孢素)、降脂药(阿伐他汀)、他丁类药物(乌司他丁)、甲氨蝶呤、抗白细胞介素1(阿那白滞素)、抗CD20单克隆抗体(利妥昔单抗)、血浆置换等。本文就IVIG无反应型川崎病患儿的治疗进展进行综述。
Kawasaki disease(KD), also known as mucocutaneous lymph node syndrome, is an agnogenic systemic vasculitis manifested as febrile and rush. The disease mainly involves small and medium-sized blood vessels. Coronary artery lesions are common, including coronary artery dilatation, coronary artery aneurysm, coronary artery stenosis and thrombosis. Immunoglobulin(IVIG) infusion combined with aspirin is a standard treatment for acute KD, but single dose of IVIG(2 g/kg) shows no significant effect on 10%-20% children with KD, which is called IVIG-resistant KD. Children with IVIG-resistant KD have a high risk of coronary artery damage especially coronary artery aneurysm. Treatments for IVIG-resistant KD include additional use of IVIG, glucocorticoids, tumor necrosis factor-α inhibitors(infliximab), abciximab, calmodulin inhibitors(cyclosporine), lipid-lowering drugs(alvastatin), statins(ulinastatin), methotrexate, anti-interleukin-1(anakinra), monoclonal antibody against CD20(rituximab) and plasma exchange. This article reviewed the progress in treatment of IVIG-reactive KD In children.
copyright
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址: 京ICP备2020043099号-3
当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。